5-Lipoxygenase and 12-lipoxygenase: attractive targets for the development of novel antipsoriatic drugs.
Müller
K
K
Institut für Pharmazie, Universität Regensburg, Germany.
D000818:Animals; D001092:Arachidonate 12-Lipoxygenase / Q000378:metabolism*; D001094:Arachidonate 5-Lipoxygenase / Q000378:metabolism*; D006801:Humans; D016859:Lipoxygenase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy* / Q000201:enzymology
D016859:Lipoxygenase Inhibitors; D001092:Arachidonate 12-Lipoxygenase; D001094:Arachidonate 5-Lipoxygenase